| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 06/10/2009 | EP2066630A1 Piperidine derivatives |
| 06/10/2009 | EP2066619A2 Soluble epoxide hydrolase inhibitors |
| 06/10/2009 | EP1844001B1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497523C Liquid crystal mixture |
| 06/09/2009 | US7544716 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease |
| 06/09/2009 | US7544682 cancer; Methyl 5-((7-(((tert-butylamino)carbonyl)amino)-6-(2,6-dichlorophenyl)pyrido[2,3-d] pyrimidin-2-yl)amino)-1,3-benzodioxole-2-carboxylate; treating cellular proliferation disorders |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009069827A1 Crystalline form of piperidine compound |
| 06/04/2009 | WO2009067847A1 Catalyst and method for selectively oxidizing primary hydroxy of protected monosaccharide |
| 06/04/2009 | WO2009036068A3 Gambogic amine, a selective trka agonist with neuroprotective activity |
| 06/04/2009 | US20090143592 Glucagon Antagonists/Inverse Agonists |
| 06/04/2009 | US20090143583 Transfection reagents |
| 06/04/2009 | US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof |
| 06/04/2009 | US20090143431 Pesticide naphthyloxy substituted phenylamidine derivatives |
| 06/04/2009 | US20090143430 Erythropoietin production accelerator |
| 06/04/2009 | US20090143397 Catechol-based derivatives for treating or preventing diabetics |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090142297 5-substituted isoindoline compounds |
| 06/03/2009 | EP2065369A1 Urea compound or salt thereof |
| 06/03/2009 | EP2064182A1 4-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 06/03/2009 | EP2063887A2 New small molecule inhibitors of mdm2 and the uses thereof |
| 06/03/2009 | EP2063710A2 Difluorinated piperidines for treatment of alzheimer's disease and related conditions |
| 06/03/2009 | EP1606288B1 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain |
| 06/03/2009 | CN101445479A Method for synthesizing 1, 4-dihydropyridine |
| 06/03/2009 | CN100494175C Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride |
| 06/03/2009 | CN100494174C Chemical synthesis process of 1-chloroformyl-4-piperidyl hydrochloride |
| 06/02/2009 | US7542575 Digital sound processing system for a vehicle |
| 06/02/2009 | US7541468 Process of preparing N-ureidoalkyl-piperidines |
| 06/02/2009 | US7541465 Substituted 2-aminoacetamides and the use thereof |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | CA2394606C New modulators of dopamine neurotransmission |
| 05/28/2009 | WO2009066072A2 Inhibitors of 17beta-hydroxysteroid dehydrogenase |
| 05/28/2009 | WO2009065570A1 Non-peptidic promoters of apoptosis |
| 05/28/2009 | WO2007110884A3 A process for the preparation of highly pure anhydrous fexofenadine hydrochloride |
| 05/28/2009 | US20090137813 metabolite of ebastine |
| 05/28/2009 | US20090137812 Process for producing 1-benzyl-4-[5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine or its salt thereof via novel intermediate |
| 05/28/2009 | US20090137811 Process for the preparation of donepezil and intermediate compounds thereof as well as hydrates of donepezil |
| 05/28/2009 | US20090137810 Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders |
| 05/28/2009 | US20090137629 Sigma receptor binding agent containing indanone derivative |
| 05/28/2009 | US20090137601 L-Phenylalanine Derivatives |
| 05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
| 05/28/2009 | US20090137561 Substituted biphenyl GPR40 modulators |
| 05/28/2009 | US20090137529 Substituted esters as cannabinoid-1 receptor modulators |
| 05/28/2009 | US20090137498 Substituted benzene derivatives or salts thereof |
| 05/28/2009 | US20090136474 Stabilized Protease Composition |
| 05/28/2009 | CA2703893A1 Compound |
| 05/27/2009 | EP2061759A1 Cyclic modulators of chemokine receptor activity |
| 05/27/2009 | EP1730141B1 Compounds for the treatment of diseases |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1244448B1 Novel methods for the treatment and prevention of ileus |
| 05/27/2009 | EP0934287B1 Heterocyclic esters and amides |
| 05/27/2009 | CN101443312A 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
| 05/27/2009 | CN101443007A TEREPHTHALAMATE compounds and compositions, and their use as HIV integrase inhibitors |
| 05/27/2009 | CN101440089A Compositions, methods and kits pertaining to luminescent compounds |
| 05/27/2009 | CN100491382C Preparation process of clopidogre and its salt |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100491348C Thrombosis resisting preparation |
| 05/26/2009 | US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 05/26/2009 | US7538227 admixing with one or more secondary and/or tertiary aliphatic or mixed aliphatic-aromatic amines |
| 05/26/2009 | US7538224 Such as 2,4-dihydroxy-6-(2-methoxyethyl)phenylphenylketone; antitumor activity; heat shock protein (Hsp) suppression |
| 05/26/2009 | US7538223 Compounds, compositions and methods |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538124 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; hyperlipidemia; antiobesity and anti-type II diabetic agents; Microsomal triglyceride transfer protein inhibitors |
| 05/26/2009 | US7538111 N(2-hydroxyethyl)-4-methoxy-N,2,6-trimethylbenzene- sulphonamide; analgesic, antiinflammatory agent; hyperalgesia and major algesia connected with other pathological conditions such as cancer |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2393559C Methods for the syntheses of alfentanil, sufentanil and remifentanil |
| 05/26/2009 | CA2242879C Method for treating sexual dysfunctions |
| 05/22/2009 | WO2009065131A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/22/2009 | CA2705947A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/21/2009 | US20090131674 Reaction product of polyamide-forming monomers additionally reacted with a monofunctional element such as stearic acid, and having basic groups such as magnesium salts of carboxylic acid; use as process aids in plastic formulations, as masterbatch carriers, binding resins for metals, ceramic; nonvolatile |
| 05/21/2009 | US20090131670 Bis-triphenylsilyl compounds and their application on organic electronic device |
| 05/21/2009 | US20090131453 Benzylpiperazine derivatives as motilin receptor antagonists |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/20/2009 | EP2060564A1 Non-peptidic promoters of apoptosis |
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2060260A1 Therapeutic agents useful for treating pain |
| 05/20/2009 | EP2059506A1 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/20/2009 | EP1773348A4 Tetrapeptide analogs |
| 05/20/2009 | EP1270549B1 Polymer-immobilized alpha-iminoester |
| 05/20/2009 | CN101437798A Mglur5 modulators II |
| 05/20/2009 | CN101437797A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 05/20/2009 | CN101437796A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 05/20/2009 | CN101437795A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 05/20/2009 | CN100488959C Water soluble thalidomide derivative |
| 05/20/2009 | CN100488949C Synthesis process of N-sustituent-4-piperidyl alcohol |
| 05/19/2009 | US7534892 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent |
| 05/19/2009 | US7534814 Mutilin derivatives and their use as antibacterials |
| 05/19/2009 | CA2525699C Processes for the preparation of s-(-)-amlodipine |
| 05/19/2009 | CA2468879C Substituted cyclohexane derivatives |
| 05/19/2009 | CA2377621C Use of nitroxides in wound healing and in the prevention of photodamage |
| 05/19/2009 | CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/19/2009 | CA2211381C Compounds with growth hormone releasing properties |
| 05/19/2009 | CA2192268C Amino alcohol derivative and method for preparing the same |
| 05/14/2009 | WO2008068540A8 New benzamide derivatives as bradykinin antagonists |
| 05/14/2009 | US20090124810 Process for production of piperidine derivatives |
| 05/14/2009 | US20090124806 Process for producing carboxylic acid from primary alcohol |
| 05/14/2009 | US20090124668 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/14/2009 | US20090124664 (R)-Arylalkylamino Derivatives and Pharmaceutical Compositions Containing Them |
| 05/14/2009 | US20090124663 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |